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Abstract: The “hybrid” approach to chronic total occlusion (CTO) percutaneous coronary interven-
tion (PCI) was developed to provide guidance on optimal crossing strategy selection. Dual angiogra-
phy remains the cornerstone of clinical decision making in CTO PCI. Four angiographic parameters 
are assessed: (a) morphology of the proximal cap (clear-cut or ambiguous); (b) occlusion length;  
(c) distal vessel size and presence of bifurcations beyond the distal cap; and (d) location and suitability of a retrograde 
conduit (collateral channels or bypass grafts) for retrograde access. Antegrade wire escalation is favored for short  
(<20 mm) occlusions, usually escalating rapidly from a soft tapered-tip polymer-jacketed guidewire to a stiff  
polymer-jacketed or tapered-tip guidewire. Antegrade dissection/re-entry is favored in long (≥20 mm long) occlusions, 
trying to minimize the dissection length by re-entering into the distal true lumen immediately after the occlusion. Primary 
retrograde approach is preferred for lesions with an ambiguous proximal cap, poor distal target, good interventional col-
laterals, and heavy calcification, as well as chronic kidney disease. The “hybrid” approach advocates early change be-
tween strategies to enable CTO crossing in the most efficacious, efficient, and safe way. Several early studies are demon-
strating high success and low complication rates with use of the “hybrid” approach, supporting its expanding use in CTO 
PCI. 
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INTRODUCTION 
 Percutaneous coronary intervention (PCI) of chronic total 
occlusions (CTOs) is challenging and technically demand-
ing, but also rapidly evolving field, which has benefited from 
remarkable equipment and technique developments during 
the past decade [1-3]. These developments have led to sig-
nificant improvement in both procedural success and com-
plication rates [4, 5], as well as increased efficiency [6]. 
 The main reason for CTO PCI failure is inability to cross 
the occlusion with a guidewire. There are three main CTO 
wiring techniques: antegrade wire escalation, antegrade dis-
section/re-entry, and retrograde; each with its own merits and 
limitations. The “hybrid” approach to CTO PCI (Fig. 1) is an 
algorithmic approach to CTO crossing that focuses on open-
ing the occluded vessel using all available techniques (ante-
grade, retrograde, true-to-true or intra-plaque lumen crossing 
or re-entry) tailored to the specific case in the most safe, ef-
fective, and efficient way [7]. The “hybrid” approach was 
created by consensus of several high-volume CTO operators 
who convened at a workshop in Bellingham, Washington in 
January 2011, and has been associated with high procedural 
success rates across several patient cohorts. 
*Address correspondence to this author at the Dallas VA Medical Center 
(111A), 4500 South Lancaster Road, Dallas, TX 75216, USA; Tel: (214) 
857-1547; Fax: (214) 302-1341; E-mail: esbrilakis@gmail.com 
DESCRIPTION OF THE “HYBRID” ALGORITHM 
Step 1: Dual Injection 
 Dual injection is probably the most important step for 
increasing procedural success and decreasing complications 
in CTO PCI [8], and should be done in all patients with con-
tralateral collaterals. Dual injection facilitates procedural 
planning by clarifying the location of the proximal and distal 
cap and the CTO length, which is almost always overesti-
mated with single injections. It also allows evaluation of the 
collateral circulation to determine whether the retrograde 
approach is feasible. Additionally, dual injection can clarify 
the guidewire and equipment location during CTO PCI 
crossing attempts, making the procedure safer.  
 Dual injection is performed by first injecting the donor 
vessel, followed by injection of the CTO target vessel 2-3 
seconds later. Low magnification can facilitate visualization 
of the entire coronary circulation, avoiding the need for pan-
ning. If automatic injectors are used, we recommend the use 
of the automatic injector on the retrograde side, and a regular 
syringe on the antegrade side, in order to avoid inadvertent 
antegrade injection during the procedure.  
Step 2: Assessment of CTO characteristics 
 Detailed angiographic review is essential for CTO PCI 
procedural planning, and should ideally be performed by the 
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entire CTO PCI team. Often, 20-30 minutes of review is 
necessary to fully appreciate the CTO anatomy and deter-
mine the optimal action plan based on the “hybrid” algo-
rithm. Ad hoc CTO PCI is discouraged because it cannot 
allow enough time for in-depth angiographic review. Moreo-
ver, staging the procedure will reduce radiation and contrast 
administration. 
 Dual injection focuses on assessment of the following 
four angiographic parameters: (a) morphology of the proxi-
mal cap (clear-cut or ambiguous); (b) occlusion length; (c) 
distal vessel size and presence of bifurcations beyond the 
distal cap (i.e., “landing zone”); and (d) location and suitabil-
ity of collateral channels or bypass grafts for retrograde ac-
cess (Fig. 2) [1, 7, 9, 10]: 
a. Proximal cap location and morphology (Fig. 
2A). Clear understanding of the CTO starting point 
is critical for both success and safety. A clearly de-
fined and unambiguous proximal cap favors up-
 
Fig. (1). Overview of the “hybrid” CTO crossing algorithm. The algorithm starts with dual coronary injection to allow assessment of several 
angiographic parameters, and allow selection of a primary antegrade or primary retrograde strategy. Strategy changes are made, depending 
on the progress of the case. Modified with permission from (7). 
  
  
Fig. (2). Four areas of focus during assessment of the angiogram in patients with coronary chronic total occlusions.  
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front use of an antegrade approach, whereas a 
poorly defined proximal cap favors a primary ret-
rograde approach. Unconventional angiographic 
projections may be needed to clarify the proximal 
location; for example, the lateral projection for 
right coronary artery occlusions. In some cases, 
angiography alone may be inconclusive, but in-
travascular ultrasound can help elucidate the 
proximal part of the CTO. Side branches at the 
proximal cap may hinder antegrade wiring, but 
could potentially be used for side branch anchoring 
to increase guide catheter support. Tapered proxi-
mal caps are more favorable than blunt caps and 
are part of the J-CTO (Multicenter CTO Registry 
in Japan) score for determining the difficulty of 
CTO crossing [11, 12]. 
b. Lesion Length (Fig. 2B). The longer the lesion, 
the more challenging crossing is likely to be, espe-
cially when the occlusion is also tortuous and cal-
cified [11]. Also, longer lesions are unlikely to be 
crossed with an exclusive intra-plaque course, the 
wire almost invariably entering and exiting the 
sub-intimal plane, even if a wire strategy is used. 
A useful cutoff point is 20 mm [11]: ≥20mm long 
lesion may be best approached with a primary dis-
section/re-entry strategy, whereas <20 mm long le-
sions are usually approached with antegrade wire 
escalation. Lesion length can be accurately as-
sessed only by using dual injections. Alternatively, 
lesion length can be estimated by performing mul-
tiple detector computed tomography prior to the 
procedure. 
c. Target coronary vessel beyond the distal cap 
(Fig. 2C). The size and quality of the vessel distal 
to the occlusion significantly affects the difficulty 
and success rate of CTO PCI. Small, diffusely dis-
eased vessels are associated with lower procedural 
success rates, in part due to difficulty re-enteringin 
the true lumen if subintimal guidewire tracking oc-
curs. The presence of a bifurcation at the distal cap 
is also an unfavorable characteristic when dissec-
tion/re-entry strategies are being utilized because 
one of the branches may be compromised during 
re-entry attempts [13]. In patients with prior coro-
nary artery bypass graft surgery (CABG) the distal 
vessel may be distorted at the distal anastomotic 
site, thus hindering wiring.  
d. Size and suitability of a retrograde conduit (Fig. 
2D). Several characteristics of the retrograde con-
duit are important, including type (septal, epicar-
dial, or bypass graft), size, tortuosity, dominance 
(wiring the only collateral that supplies the vessel 
distal to the occlusion may cause severe ischemia), 
angle and location of entry into the distal vessel. 
Ideally, the collateral donor vessel would have 
minimal disease and tortuosity; otherwise, PCI of 
the donor vessel may be needed before retrograde 
CTO PCI. The collaterals should ideally enter the 
CTO vessel at a sufficient distance from the distal 
cap to allow enough “landing zone” for retrograde 
equipment. Septal channels can even be wired and 
crossed despite being barely visible, or even when 
they are invisible. Bypass grafts anastomosed to 
the target vessel can be also used as retrograde 
conduits to facilitate CTO PCI, even if they are oc-
cluded [14, 15]. The presence of well-developed 
and suitable collaterals favors earlier use of retro-
grade technique during CTO PCI, although this is 
highly dependent on operator experience.  
Step 3: Antegrade Wiring 
 Antegrade wiring is favored as the initial approach in 
short (<20 mm long) occlusions, and is performed by using 
guidewires of increasing stiffness to cross a CTO. The initial 
choice of wires and subsequent escalation pattern is variable 
across operators and CTO PCI schools of thought, however, 
most operators currently start with a soft tapered-tip poly-
mer-jacketed guidewire (such as the Fielder XT wire, Asahi 
Intecc; Nagoya, Japan). If this wire fails to cross, hybrid op-
erators currently favor a rapid escalation using a stiff poly-
mer-jacketed wire (such as the Pilot 200, Abbott Vascular; 
Santa Clara, California) if the course of the CTO is unclear, 
or a stiff tapered-tip guidewire (Confianza Pro 12, Asahi 
Intecc or Gaia 2nd, Asahi Intecc) if the course of the CTO is 
well understood. Shaping of the wire is crucial; a 1 mm short 
and about 30⁰ bend at the tip is typically used. Support from 
a microcatheter is also warranted.  
Step 4: Antegrade Dissection and Re-Entry 
 The “hybrid” algorithm recommends upfront use of ante-
grade dissection/re-entry for long (≥20mm) lesions ap-
proached in the antegrade direction because of low likeli-
hood of maintaining intimal wire position with antegrade 
wire escalation. Extensive dissection/re-entry strategies, such 
as the subintimal tracking and re-entry (STAR) technique, 
should be avoided because they are associated with high 
restenosis and re-occlusion rates [16, 17]. Limited dissec-
tion/re-entry strategies are preferred, as they limit side 
branch loss, stent length, and likely, the risk for restenosis 
[18]. 
 Dissection can be performed either by advancing a 
“knuckle” created by bending the tip of a polymer-jacketed 
guidewire (usually Fielder XT or Pilot 200) or by using the 
CrossBoss catheter (Boston Scientific; Natick, Massachu-
setts) [19]. The CrossBoss catheter has a 1 mm round distal 
atraumatic blunt tip and is advanced using a rapid-spin tech-
nique [20]. The advantage of dissection compared to wire 
escalation techniques is the lower risk for perforation (the 
knuckle or the tip of the CrossBoss catheter are deflected by 
the adventitia and are unlikely to exit the vessel structure, 
whereas the tip of a guidewire is much more likely to perfo-
rate) and faster speed.  
 Re-entry can be achieved using guidewires or using the 
Stingray system (Boston Scientific). Wire-based re-entry can 
be performed with the “mini-STAR” [21] or the Limited 
Antegrade Subintimal Tracking (LAST) [22] techniques. 
The Stingray system consists of the Stingray balloon and 
guidewire. The Stingray balloon has a flat shape with two 
side exit ports, and is designed to self-orient one exit port 
towards the true lumen upon low-pressure (2-4 atm) inflation 
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[19]. The Stingray guidewire is a 12 gram guidewire with a 
20 cm distal radiopaque segment and a 0.009ʺ tapered tip 
with a 0.0035ʺ distal prong, and is advanced through the side 
port of the Stingray balloon facing the distal true lumen un-
der fluoroscopic guidance to achieve re-entry [20, 23-25]. 
Step 5: Retrograde 
 In the retrograde approach, the CTO is approached from 
the distal vessel by advancing a guidewire into the artery 
distal to the occlusion through a collateral vessel or bypass 
graft [26, 27]. The retrograde approach has been one of the 
major reasons for increased CTO PCI procedural success 
rates [28-31], but also requires specialized training and 
equipment. The retrograde technique is preferred for lesions 
with an ambiguous proximal cap, poor distal target, good 
interventional collaterals, and heavy calcification, as well as 
patients with chronic kidney disease (contrast use is limited 
by utilizing the retrograde approach) [1].  
Step 6: Change 
 In addition to providing guidelines on selection of the 
initial crossing strategy, the “hybrid” approach advocates 
early change of crossing strategy if the initially selected ap-
proach fails to make progress within a reasonable period of 
time. This is a simple, yet radical conceptual change in CTO 
PCI. Prior to the “hybrid” approach, if an antegrade CTO 
PCI attempt failed, most operators stopped and re-attempted 
CTO PCI using an alternative strategy (such as the retro-
grade approach) during a repeat procedure. In contrast, in the 
“hybrid” approach change from one crossing strategy to an-
other is often performed during the same procedure. Rapid 
change maximizes the efficiency of the procedure by mini-
mizing the time spent on non-productive efforts. It also re-
duces radiation exposure and contrast utilization, which in 
turn increases the likelihood of procedural success. To allow 
for seamless and prompt changes, expertise in all crossing 
techniques (antegrade wire escalation, antegrade dissec-
tion/re-entry, and retrograde) is needed. 
OUTCOMES WITH USE OF THE “HYBRID” AP-
PROACH 
 Several studies were recently published demonstrating a 
positive impact of the “hybrid” approach in achieving high 
success and low complication rates (Table 1) [10, 12, 32-36]. 
Moreover, the “hybrid” approach has been used as a frame-
work for training interventionalists in CTO PCI. 
 Nombela-Franco et al. validated the J-CTO score in a 
series of 209 consecutive patients who underwent hybrid 
CTO PCI by a high-volume operator [12]. The J-CTO score 
was applied for each patient and discrimination and calibra-
tion were evaluated in the whole cohort, and according to the 
approach (antegrade 47% and retrograde 53%). Despite a 
mean J-CTO score of 2.18±1.26 (difficult cases), successful 
guidewire crossing within 30 minutes and final angiographic 
success were 44.5% and 90.4%, respectively. The J-CTO 
score demonstrated good discrimination and calibration [12]. 
However, the final success rate was not predicted by the J-
CTO score. These findings suggest that a liberal use of a 
hybrid antegrade and retrograde approach and dissection-
reentry technique is likely to overcome the impact of com-
plexity on success rate [12]. 
 Michael et al. described application of the “hybrid” ap-
proach in 73 consecutive CTO PCI cases performed by a 
single operator [10]. Dual injection was used in 78%. Tech-
Table 1. Publications on the use of “hybrid” approach to chronic total occlusion interventions as of May, 2014. 
Author Year n Comment 
El Sabbagh [32]  2012 1 First published case report on use of the “hybrid” approach 
Nombela-Franco 
[12]  
2013 209 Technical success was 90.4%, despite mean J-CTO score of 2.18±1.26 (difficult cases). The 
J-CTO score demonstrated good discrimination and calibration. However, final success rate 
was not predicted by the J-CTO score with the hybrid approach. 
Michael [10]  2014 73 Technical success was 90.4%. A crossing strategy change was needed in 44% of cases. Final 
successful crossing strategy was antegrade wire escalation in 50.0%, antegrade dissection/re-
entry in 24.2%, and retrograde in 25.8% 
Pershad [33]  2014 198 Technical success was 95.4% in the post “hybrid” algorithm group vs. 79.4% among patients 
treated before introduction of the “hybrid” algorithm. 
Christopoulos [35]  2014 497 Technical and procedural success was achieved with the “hybrid” approach in 91.5% and 
90.7% of cases, respectively, and were significantly higher than the pooled technical and 
procedural success rates from previously published studies (76.5%, p<0.001 and 75.2%, 
p<0.001, respectively). Major procedural complications occurred in 1.8% of patients, an 
incidence similar to that of prior studies (pooled rate 2.0%, p=0.72) 
Christopoulos [36]  2014 496 Technical and procedural success was lower among patients with previous CABG (88.1% vs. 
93.4%, p = 0.044 and 87.5 vs. 92.5%, p = 0.07, respectively). 
Christopoulos [34]  2014 521 Technical success in the in-stent restenosis and de novo group was 89.4% vs. 92.5% 
(p=0.43), respectively; procedural success was 86.0% vs. 90.3% (p=0.31), respectively; and 
the incidence of major adverse cardiac events was 3.5% vs. 2.2%, respectively (p=0.63). 
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nical success was 90.4% and the incidence of complications 
was 4.1%. The primary approach was antegrade in 87.5% of 
cases, of which 39.1% underwent retrograde attempt after 
failure of the antegrade approach. The initial crossing ap-
proach succeeded in 54.8%, however, an approach change 
was required in 44% of cases with a mean of 3.6±1.4 ap-
proach changes. Antegrade wire escalation, antegrade dissec-
tion/re-entry, and retrograde crossing were utilized in 97.2%, 
46.6%, and 46.6% of cases, respectively. Among successful 
cases, the final CTO crossing technique was antegrade wire 
escalation in 50.0%, antegrade dissection/re-entry in 24.2%, 
and retrograde in 25.8% [10]; which highlights the impor-
tance of expertise in all CTO crossing techniques to achieve 
optimal outcomes. 
 Pershad et al. reviewed outcomes before and after adop-
tion of the “hybrid” approach in two high-volume centers 
[33]. In 660 cases (462 performed before and 198 performed 
after “hybrid” approach implementation), both technical 
(95.4% vs. 79.4%, P<0.001) and procedural (88.3% vs. 
77.9%, P<0.001) success significantly improved. Antegrade 
wire escalation was used in 39.3% of cases, with an overall 
success rate of 87.1%; antegrade dissection/re-entry was 
used in 28.7%, with an overall success of 94.7%; and the 
retrograde approach was used in 35.3% of cases, with an 
overall success rate of 78.8% [33]. 
 Christopoulos et al. analyzed outcomes of 497 CTO PCI 
cases from an ongoing multicenter registry (Prospective 
Global Registry for the Studyof Chronic Total Occlusion 
Intervention – PROGRESS CTO, NCT02061436) [35]. 
Technical and procedural success was achieved in 91.5% and 
90.7% of cases, respectively, and were significantly higher 
than the pooled technical and procedural success rates from 
previously published studies (76.5%, p<0.001 and 75.2%, 
p<0.001, respectively). Major procedural complications oc-
curred in 1.8% of patients, an incidence similar to that of 
prior studies (pooled rate 2.0%, p=0.72) [35]. 
 In two subsequent analyses from the same registry the 
outcomes of patients with prior CABG [36] and those with 
CTOs due to in-stent restenosis (ISR) [34] were explored. 
 Thirty-five percent of CTO PCI patients had prior 
CABG. Prior CABG patients were older, had more coronary 
artery disease risk factors, and had less favorable angi-
ographic CTO characteristics [36]. The retrograde approach 
was more commonly used among prior CABG patients (in 
39% vs. 24%, p <0.001). Technical and procedural success 
was slightly lower among patients with previous CABG 
(88.1% vs. 93.4%, p=0.044 and 87.5 vs. 92.5%, p = 0.07, 
respectively), whereas major procedural complications were 
similar in the two groups: 1.1% among patients with prior 
CABG vs. 2.1% of patients without prior CABG [36].  
 CTO due to ISR represented 10.9% of the overall CTO 
PCI cases and was associated with higher frequency of dia-
betes, less calcification, but longer occlusion length [34]. 
Technical success in the ISR and de novo group was 89.4% 
vs. 92.5% (p=0.43), respectively; procedural success was 
86.0% vs. 90.3% (p=0.31), respectively; and the incidence of 
major adverse cardiac events was 3.5% vs. 2.2% (p=0.63), 
respectively [34]. 
CONCLUSION 
 The “hybrid” approach to CTO PCI has emerged as a 
valuable guide to CTO PCI. It builds on the value of dual 
coronary angiography, and emphasizes the importance of 
careful and detailed review of the angiographic images to 
develop a procedural plan. The plan is flexible, allowing 
several “what if” scenarios. The “hybrid” approach enables 
excellent procedural results in experienced centers and forms 
a central platform for procedural planning and execution, as 
well as for teaching and widespread dissemination of CTO 
PCI techniques. 
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